Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

De novo chemo-optogenetics through the rational design of photoresponsive molecules and selection of their artificial protein binding pairs.

PMID: 42026173 · 2026

JournalNature chemistry
Year2026
PMID42026173

Abstract

Optical manipulation of proteins is central to probing and engineering cellular functions. However, existing optogenetic tools based on natural photoreceptors and chemo-optogenetic tools based on natural protein-ligand pairs are difficult to reconfigure for the desired photochemical and binding properties. Here we introduce a de novo approach for creating chemo-optogenetic tools. Instead of modifying pre-existing ligands, we first design a synthetic photoswitch with defined properties and then u

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.